Free Trial

William Blair Predicts Increased Earnings for Henry Schein

Henry Schein logo with Medical background

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities researchers at William Blair boosted their FY2024 earnings estimates for Henry Schein in a report released on Tuesday, November 5th. William Blair analyst B. Vazquez now expects that the company will earn $4.78 per share for the year, up from their prior forecast of $4.74. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein's Q2 2025 earnings at $1.30 EPS, Q3 2025 earnings at $1.30 EPS and FY2026 earnings at $5.59 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The company had revenue of $3.17 billion during the quarter, compared to analysts' expectations of $3.24 billion. During the same quarter in the prior year, the company earned $1.32 EPS. Henry Schein's revenue was up .4% compared to the same quarter last year.

Several other analysts have also recently issued reports on the company. Barrington Research restated an "outperform" rating and issued a $82.00 target price on shares of Henry Schein in a report on Wednesday. Baird R W raised shares of Henry Schein from a "hold" rating to a "strong-buy" rating in a research note on Monday, July 22nd. UBS Group dropped their price target on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research note on Wednesday, August 7th. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday. Finally, Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an "outperform" rating for the company in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Henry Schein presently has an average rating of "Hold" and a consensus price target of $77.50.

Read Our Latest Stock Analysis on HSIC

Henry Schein Price Performance

Shares of HSIC stock traded down $1.43 during trading hours on Friday, reaching $68.00. The company had a trading volume of 871,840 shares, compared to its average volume of 1,357,247. Henry Schein has a 12-month low of $62.12 and a 12-month high of $82.63. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.90 and a current ratio of 1.55. The company has a market capitalization of $8.62 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 2.08 and a beta of 0.87. The stock has a fifty day moving average of $70.56 and a 200-day moving average of $69.78.

Insider Activity

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 1.14% of the company's stock.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently bought and sold shares of HSIC. Cromwell Holdings LLC raised its holdings in Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after acquiring an additional 170 shares in the last quarter. Summit Securities Group LLC acquired a new position in shares of Henry Schein during the second quarter worth $31,000. Beach Investment Counsel Inc. PA purchased a new position in Henry Schein in the second quarter valued at $37,000. Blue Trust Inc. raised its stake in Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after buying an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its holdings in Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock worth $68,000 after buying an additional 346 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company's stock.

About Henry Schein

(Get Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History and Estimates for Henry Schein (NASDAQ:HSIC)

Should you invest $1,000 in Henry Schein right now?

Before you consider Henry Schein, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.

While Henry Schein currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Revolutionizing Logistics: Dot Ai Corporation CEO Ed Nabrotzky Talks IPO and Innovations
Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar
Top 3 Stocks Under $20 with Strong Buy Ratings and Growth Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines